CONFERENCE FORMAT CHANGE
No Need to Travel. We’re Coming to You Virtually!
Due to social distancing and large group gathering restrictions, ACI’s Paragraph IV Disputes has changed format from a live, in-person event to an interactive, virtual conference.
REGISTER NOW & RECEIVE A SPECIAL BONUS
Register by August 14, 2020 and you will receive complimentary registration to our Paragraph IV on Virtual Trial
This new one-day virtual event will guide you through the many procedural dilemmas that ANDA litigators are experiencing as a result of the novel coronavirus and provide solutions to coronavirus-related disruptions to Hatch-Waxman litigation.
Meet And Network With The Key Influencers Shaping The Law, Policy And Proceedings of Paragraph IV Litigation
Each year, leading pharmaceutical patent litigators for brand name and generic drug companies gather at the Paragraph IV Disputes conference to discuss, debate, and analyze the latest trends, judicial rulings and legislative developments affecting Hatch-Waxman litigation.
As the industry prepares to address the fall out of global pharmaceutical patent losses of billions of dollars on the Hatch-Waxman landscape, the time for this conference has never been more relevant.
Principal Counsel, Patent Litigation
Pearl T. L. Siew
Senior Vice President and Head, Intellectual Property
Eagle Pharmaceuticals, Inc.
2020 Key Features
FTC KEYNOTE ADDRESS
Insights on antitrust developments impacting brands and generics
DISTRICT COURT INSIGHTS
Interactive discussions with District Court Judges and Magistrate Judges from D.N.J.; E.D. Pa.; E.D. Tex.
FOUR NEW BREAKOUT TRACKS
Featuring an In-House Solutions Studio and Litigators War Room
SPECIAL FOCUS SESSIONS ON THE PTAB
APJs Roundtable and advanced discussions on policy, practice, procedure, and the Appointments Clause
FDA THINK TANK
Initiatives impacting drug access and litigation
SPOTLIGHT ON DELAWARE
A Conversation with Chief Judge Stark and Chief Magistrate Judge Thynge
Attend the conference that the “Who’s Who” of Hatch-Waxman litigators have designated as the forum which sets the standards for Paragraph IV practice. Register now and be part of the prestigious meeting of the minds.Register Now
Who You Will Meet
Patent attorneys and litigators (in-house & law firms) who represent:
- Brand name pharmaceutical companies
- Generic pharmaceutical companies
- Biopharmaceutical companies
…the smaller breakout sessions allow participants to tailor their conference experience to meet their specific needs, and exchange ideas in an intimate and dynamic environment.
This is the best high-level conference on Paragraph IV disputes…